Answer
Not reliably. Commercial assays can give falsely elevated anti-factor Xa activity after treatment, so response is monitored mainly through haemostasis, rebleeding and adverse events.
Sources for this answer
- Ondexxya 200 mg powder for solution for infusionemc · SmPC Current selected SmPC · Version 17
- UK GovernmentUK Government · Reputable Web